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That  sterile  faltered  inflammatory  exudates  have  the  power  to  modify the 
course  of  infection  was  noted  long  ago.  The  chief  discussion  concerning  the 
nature of this phenomenon has been carried on by Bail and his associates and by 
those  who  have  contraverted  their  views.  Bail  t gave to the hypothetical sub- 
stances  existing  in  pathological  exudates,  which  alter  the  course  of infection, 
the  name  "aggressins."  He  thought  that  they  were  secreted  by the  bacteria 
during their growth in the animal body and acted by inhibiting or by neutralizing 
the defensive mechanisms of the body.  According to  this  investigator  it  is  to 
these substances that the bacteria owe their power to invade the body tissues and 
therefore  it  is  upon  their  ability  to form them  that  the  property *of virulence 
depends. 
Wassermann  and  Citron  s have  opposed the view of Bail  that these so called 
aggressins  represent  substances  set  free  by the  bacteria  during  their  struggle 
against  the  protective  agencies  of  the  body,  and  believe  that  they represent 
merely bacterial substances which may go into solution either within the body or 
during growth or autolysis in vitro, and that  these substances  act by fixing the 
humoral  immune  bodies  and  so  rendering  them  ineffective;  that  the  mode  of 
action of these  substances therefore does not differ from that  of dead  bacteria. 
It is not german to the present discussion to consider the large amount of evidence 
which has been brought forward to support the  contending views, the chief pur- 
pose of the present paper being to record the demonstration of large amounts of 
substances  which neutralize  immunity principles  in the  blood  and  exudates  of 
animals  infected  with  pneumocoeci,  and  to  indicate  the  importance  of  these 
substances in the specific therapy of acute lobar pneumonia. 
The  part  which  these  substances  play  in  experimental  pneumococcus infec- 
tions, especially  their  effect  on  phagocytosis,  has been studied by Hoke,  3 Rose- 
1 Bail, 0., Arch. Hyg.,  1905, lii, 272. 
Wassermann, A., and Citron, J., Deutsch. reed. Woch., 1905, xxxi,  1101. 
3 Hoke, E., Wien. klin. Woch., 1905, xviil,  348. 
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now,  4 Tschistowich and Jurewich,  s Zade,  6 and  Nunokawafl Tschistowich and 
Jurewich have made the  observation that  thoroughly washing virulent,  non- 
phagocytable pneumococci in salt solution is sufficient to render them phago- 
cytable.  Rosenow, as well as  Tschistowich and  Jurewich, has also observed 
that treating non-virulent, phagocytable pneumococci with the washings from, 
or extracts of virulent pneumococci is sufficient  to render the former non-phago- 
cytable and therefore virulent, and he has found that this property is retained 
even after washing in salt solution.  This writer has given to the hypothetical 
substances which may be extracted from virulent pneumococci the name "viru- 
lin," and Tschistowich and Jurewich have given to the substances which they 
have obtained by somewhat similar methods the name "anti-phagln." 
It is evident that these observations, especially those of Rosenow, 
would render necessary  an  entirely different conception of the phe- 
nomenon from that held by Wassermann and Citron. 
In  a  considerable number  of experiments, however,  I  have  been 
unable  to  confirm  the  observations  of  Rosenow  that  non-virulent 
pneumococci  may  absorb  and  fix something derived from virulent 
pneumococci which renders the former virulent, and for the present, 
therefore, I  am inclined to accept the explanation offered by Wasser- 
mann  and  Citron,  especially  since  this  conception is  sufficient to 
explain all the following observations. 
The first observations on which this communication is based were 
made on the fluid removed from the chests of persons suffering from 
empyema.  The fluid from these cases was  examined  for its content 
in pneumococcus immune bodies as tested by agglutination and pro- 
tection.  Similar tests of the patient's blood showed that it possessed 
well  marked  protective  and  agglutinative properties,  and  we  were 
therefore surprised when we found that the empyema fluid possessed 
no such powers.  A probable explanation seemed to be that, although 
the immune bodies were originally present in the exudate, they had 
been  absorbed  by  the  bacteria  present,  just  as  they may be  from 
immune blood serum when bacteria are added in vitro.  It occurred 
to us, however, to test this empyema fluid after removal of bacteria, 
to determine whether or not there might be present soluble substances, 
4  Rosenow, E. C., J. Infect. Dis., 1907, iv, 285. 
Tschistowicb, N., and Jurewich, Y., Ann. Inst. Pasteur, 1908, xxii,  611. 
6  Zade, M., Z. Immuniti~tsforsch.,  Orig.,  1909, ii, 81. 
7  Nunokawa, K., Z. Immunitatsforsch.,  Orig.,  1909, iii, 172. Rwvs  COLE  455 
which would fix or divert the immune substances contained in immune 
serum.  The following is a  protocol of one experiment. 
Case 1.--E. R.; age 19 years.  Acute lobar  pneumonia followed by empyema 
due to Pneumococcus Type I.  200 cc. of thick pus were removed at  operation. 
A portion of the fluid was centrifugalized at high speed for 30 minutes, the super- 
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TEXT-FIG.  1.  Protocol  of  an  experiment  showing  the  inhibiting  action  of 
empyema fluid on the agglutination of pneumococci by immune serum. 
natant  fluid was removed to a  fresh centrifuge tube  and  again  centrifugaiized 
for 1 hour, and finally diluted with an equal quantity of isotonic saline solution 
and again centrifugaiized for 30 minutes.  The perfectly clear fluid as examined 
mi roscopically contained no organisms. 
This fluid was then tested for its power to cause agglutination of Type I pneu- 
mococci and  also for its power to inhibit  the agglutination  of pneumococci by 
Type I immune serum.  The results are given in Text-fig. 1. 456  /KNTIPNE~OCOCCUS  I~E  BODIES 
The fluid  was then tested for its power to inhibit  the  protective action  of 
immune serum against infection with Type I pneumococci as tested in mice.  To 
guard against the possibility that the fluid, centrifugalized as noted above, might 
contain  an occasional  pneumococcus which  might interfere with  the result,  it 
was heated for 30 minutes at 56°C.  Cultures made from this fluid were sterile, s 
Text-fig. 2 gives the results of this experiment.  They  show  in  a  striking  way 
that empyema fluids may  contain  large  amounts  of  soluble  substances  which 
inhibit the action of immune serum. 
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TExT-Fx6.  2.  Protocol  of  an  experiment  showing  the  inhibiting  action  of 
empyema fluid on the protection of mice by immune serum. 
Similar tests have been carried out with a  series of these empyema 
exudates  removed by  aspiration  or  at  operation.  The  results  have 
not  been so striking in  all the  cases examined as  those  shown in the 
above protocol,  though  some  degree  of  inhibition  has  been  present 
in  all infected cases.  Several sterile serous fluids aspirated from the 
chest  of  pneumonia  patients,  however,  have  not  exhibited  this 
phenomenon.  The degree of inhibiting action is apparently depend- 
ent upon the degree of infection and the time the infection has lasted 
before aspiration is performed. 
These observations indicate why it is that infections in  the  parti- 
ally immunized  animal  tend  to  be  focal  and  why,  when  an  animal 
is infected with  organisms of slight virulence, the  infection  tends to 
remain  localized.  It  is  probable  that  as  soon  as  bacteria  begin  to 
grow  in  tissue  spaces  these  inhibiting  substances  appear  in  the  in- 
s In making the  tests with mixtures of serum and  fluid,  the  mixtures  were 
allowed to incubate for 30 minutes at 37°C. before injection. RUFUS  COLE  457 
flammatory exudate,  and when the fluid is not readily absorbed the 
substances accumulate in large amounts, so that finally, as in empy- 
ema, it is practically impossible to produce a focal immunity reaction 
until  the focus is opened and the fluid, with its content of neutraliz- 
ing substance, is removed by drainage,  when the bacteria remaining 
are no longer protected from the natural or artificial defensive mechan- 
isms of the body and so may be overcome.  This  conception agrees 
in the main with the view held by Bail and others, though the appli- 
cation of the theory has previously been made rather to the problems 
of virulence  and infection  than  to those of recovery.  The  observa- 
tions  previously mentioned  also indicate  that  favorable results  can 
hardly be expected from the treatment  of these focal infections with 
immune serum, either administered intravenously or injected directly 
into  the  focus itself unless  the  pathological  exudate  has  previously 
been removed.  We have made one attempt to treat a patient suffer- 
ing from empyema by the direct injection of immune serum into the 
cav:ty,  but  without  apparent  effect.  These  observations  offer  the 
explanation for the failure.  In the treatment of focal infections with 
immune  serum,  without  drainage,  it  would be  necessary  to  inject 
sufficient  serum  to  neutralize  all  the  inhibiting  substances  present, 
as well as the amount necessary to prevent the harmful  activities of 
the bacteria themselves. 
Our  next  problem  was  to  discover whether  or not  the  inhibiting 
substances appear in the blood as a  result of septicemia.  This was 
first  investigated  by inoculating  rabbits  with  very large  injections 
of pneumococcus  and  testing  the  blood removed  during  the  height 
of infection for the presence of these substances.  To show that this 
action is due to soluble substances,  and not to the bacteria present, 
the bacteria have been removed from the serum by filtration before 
testing.  The  results  of  one  of  these  experiments  are  given in the 
following protocol. 
Rabbit/.--Weight 1,300 gin. July 11, 1916, 12 noon. Inoculated  intraperito- 
neally with 1 cc. of peritoneal exudate of a rabbit previously infected with Type II 
pneurnococci.  5 p.m.  Blood  culture shows  innumerable numbers of pneumococci. 
July  12,  10  a.m.  Animal very sick.  Blood  removed  by heart  puncture. 
Serum removed from clot and passed through a Berkefeld filter.  Culture of fil- 
tered blood sterile.  The filtered blood was tested for its power to  inhibit  the 458  ANTIPNEUMOCOCCUS  IMMUNE  BODIES 
agglutinating action of immune horse serum, Type II.  Table I  shows  the results 
obtained. 
TABLE  I. 
Agglutination. 
0.4  cc.  of  Immune  Serum  II  (1: 40)  +  0.4 cc.  of  fil- 
tered  serum ...................................... 
0.4  cc.  of  Immune  Serum  II  (1: 50)  -[- 0.4  cc.  of fil- 
tered serum ...................................... 
0.4  cc.  of  Immune  Serum  II (1: 100)  +  0.4  cc.  of fil- 
tered serum ...................................... 
0.4  cc.  of  Immune  Serum II  (1:200)  +  0.4  co.  of fil- 
tered  serum ...................................... 
0.4 cc.  of Immune  Serum II  (1 : 40)  -b  0.4 cc.  of  salt 
solution .......................................... 
0.4  cc.  of Immune  Serum II  (1: 50)  -4-  0.4 cc.  of  salt 
solution .......................................... 
0.4 cc.  of Immune  Serum  II  (1: 100)  -4-  0.4 cc.  of salt 
solution .......................................... 
0.4 cc.  of Immune  Serum II  (1:200)  -4-  0.4 cc.  of salt 
solution .......................................... 
0.4 cc.  of Immune  Serum  II  (1:400)  +  0.4 cc.  of salt 
solution ......................................... 
0.8 cc. of salt solution  ............................... 
After 30 minutes al 
37°C.  0.1  cc.  of 
Culture  II  was 
added  to  each 
tube. 
Results 
after 2 hzs, 
at  37°C. 
and 18 hrs. 
on ice. 
++ 
++ 
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The results of this and  other  similar  experiments  show  that  spe- 
cific inhibiting  substances such as those which are present in patho- 
logical exudates may also be present in the blood when an animal  is 
suffering from a severe septicemia. 
Another  method  which  has  been used for  testing  the presence  of 
inhibiting  substances in  the  blood is  the  following.  A  rabbit is in- 
fected with pneumococci and after the infection has reached its height 
immune serum is injected intravenously.  At the same time, and as a 
control,  a normal rabbit receives the same amount of immune serum 
intravenousIy.  Within  a  few  minutes  and  at  varying  periods  fol- 
lowing  the  injection  of  the  serum,  samples  of  blood  are  removed 
from  both  rabbits  and  tested  for  their  content  in  antibodies.  For 
this  purpose  agglutination  is  employed.  If  no  neutralization  of 
antibodies occurs, it is evident that the  content of the  blood in agglu- ~vFvs  COLE  459 
tinins  immediately  following  the  injection  should  be  the  same  as 
though  the immune  serum had been diluted in vitro with a  quantity 
of fluid equal to the blood contained in the rabbit, and that by making 
repeated  tests  a  curve  showing  the  disappearance  of  the  immune 
bodies t~y destruction or excretion may be constructed.  As a matter 
of  fact,  numerous  observations  in  normal  rabbits  have  shown  that 
when the rabbit's b]ood is tested within  a  few minutes following the 
injection  of immune  serum,  its  content  in  agglutinins  is  about  that 
to  be expected when the probable volume of blood in the rabbit and 
the consequent dilution  of the immune  serum is calculated.  On  the 
other hand,  when a  similar injection is made into an infected animal, 
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T~xT-FIG. 3.  Curves showing the agglutinating power of the serum of normal 
and infected rabbits following the injection of immune horse serum. 
the agglutinating  power of  the serum obtained  from it is much  less 
than  that  calculated  from  the  probable  dilution;  indeed,  aggluti- 
nating  power may  be  entirely  absent.  Moreover,  when  the  agglu- 
tinating  power  is  present,  though  lower  than  that  of  the serum  of 
the  normal  rabbit, and  curves  are  made  to  show the  disappearance 
of the agglutinating  power, it is found that the agglutinins  disappear 
much more rapidly from the serum  of the infected rabbit  than  they 
do from the serum of the uninfected rabbit.  Text-fig.  3  shows in a 
graphic manner  the results obtained in one of these experiments. 
In  these  experiments  the  possibility cannot  be  excluded  that  the 
fixation or neutralization of antibodies is due to the presence of bacteria 
circulating  in  the  rabbit's  blood, but previous  observations make  it 460  ANTIPNEUMOCOCCUS  IMMUNE  BODIES 
improbable that  the entire phenomenon can be due to this.  It seems 
probable  that  the  neutralization  is  due  to  a  considerable  extent  to 
the presence of soluble inhibiting  substances. 
This  last  method  of  study is  directly  applicable  to  patients,  and 
a  study of this  kind  in patients  is  of importance  since it is  dif~cult 
to produce  in  animals  pneumococcus  infections  which  last  over  a 
period  of  a  week  or  longer,  such  as  those  which  occur  in  man. 
Moreover,  it  was  hoped that  this study would offer  indications  for 
proper  dosage of serum  and  might  even  be  applicable  in  the  treat- 
ment  of  the  individual  case.  In  a  series  of  cases,  therefore,  the 
serum has been tested for its content in agglutinating  antibodies both 
before and following the  administration  of immune  serum. 
The method of procedure was as follows:  Samples of the patient's 
serum were obtained before any immune serum was administered and 
also 5  minutes  following the first  dose.  Where  more  than  one  dose 
was administered  (and successive doses have usually been given with 
6  to  8  hour  intervals)  other  samples  were  obtained  immediately 
before  and  5  minutes  following  each  subsequent  dose.  Finally, 
following  the  last  dose,  in  certain  cases,  samples  were  obtained  at 
varying periods to observe the persistence of agglutinins in the blood. 
The  samples  from  each  patient  were kept  on  ice until  all  had  been 
obtained  and  they were  then  tested  on  the  same  day  and  with  the 
same  technique  for  the  presence  of  agglutinins.  The  agglutination 
tests were made by the macroscopic method.  In each  of a  series of 
small  test-tubes  was  placed  0.9  cc.  of  the serum,  or  of  the  diluted 
serum.  To each  of the  tubes was then  a~lded  0.1  cc.  of an  18 hour 
broth culture of pneumococcus of the type to which the infection was 
due and  corresponding  to the  serum which had been injected.  The 
results  were  read  by  transmitted  light  after  2  hours  at  37°C.  and 
again after the tubes had remained on ice over night. 
Employing  these  methods,  agglufinin  curves  have  been  made 
from  30  cases suffering from  Type I  infection  and  receiving  serum, 
9  cases  suffering  from  Type  II  infection,  and  also  serum  treated, 
7  cases  with  Type II infection,  who received no  serum,  4  of  Type 
III,  not  serum  treated,  2  of  Type  IV  not  serum  treated,  and  1 
case due to Type IV infection who,  through  a  mistake in diagnosis, 
received several doses of Type I  serum, making a total of 53 cases. gu~us  COLE  461 
Cases Due to Type I  Infection Treated with Serum. 
Of  these  cases,  3  were  treated  on  the  2nd  day,  5  on  the  3rd  day, 
5  on the 4th day, 4  on the 5th day, 9  on the 6th day, 3 on the 7th day, 
and  1  on  the  9th  day.  All  but  two  of  the  cases  recovered.  The 
charts  and  protocols  of several  cases,  which illustrate  the  relation  of 
agglufinin  titer  to  the  clinical  course  and  to  the  temperature  curve, 
are given below. 
Case I.--R. R., student; age 22 years.  This patient was admitted January 8, 
1917 at 7 p.m. suffering from pneumonia involving the left lower lobe.  The onset 
had been  quite  typical with chill,  48 hours before admission.  He was moder- 
ately  sick;  temperature  102.5°F.,  pulse'  115,  respirations  30.  The  leukocytes 
numbered 31,000 and the blood culture was positive, the plates showing one colony 
per cc. of blood.  The sputum was bloody; a small amount was at once inoculated 
into a mouse.  The following morning tests made of the grovcth in the peritoneal 
cavity of the mouse showed that the patient was suffering from an infection with 
Type I pneumococci.  12.17 p.m.  The intravenous injection of antipneumococcus 
serum  was commenced.  Althqugh  the  serum  was  given slowly,  after  he  had 
received about 35 cc. he had some signs of serum intoxication, suffusion of the 
face,  respiratory difficulty, and he  vomited several times.  The administration 
of serum was therefore at once discontinued.  No tests were made of the agglu- 
tinating power of his serum before or after this treatment.  The patient's con- 
dition did not materially change during the afternoon and at 5  p.m. serum was 
again administered; this time 80 cc. were given without any untoward symptoms. 
A sample of blood was taken just before and another one 5 minutes following the 
administration  of the serum.  When tested later,  it  was found that  the  blood 
before administering the serum contained no agglutinins for pneumococcus;  the 
sample of blood taken following the administration of serum  agglutinated  Type I 
pneumococcus in a  dilution  of  1:15.  This  represents  a  concentration of anti- 
bodies fully equal to that which might be expected, taking into consideration the 
titer of the serum injected and the probable volume of the patient's blood.  The 
patient's condition did not materially improve after this injection, so that another 
dose of 90 cc. of serum was administered  at  12 midnight.  A  specimen of blood 
which was obtained just before this injection showed that the agglutinating power 
had not diminished during the time intervening since the preceding dose, and the 
specimen of blood taken  5 minutes after the serum was injected showed an in- 
creased concentration of aggiutinins,  so that now agglutination occurred with a 
1:30 dilution  of serum.  Immediately following this  injection the  temperature 
rose to 106°F.  and he had a shaking chill.  The temperature  then began to fall, 
being only 98.1°F. at 8 a.m.  With this fall in temperature, the patient's condition 
markedly improved.  During the day, the temperature again rose slowly, without, 
however,  any other unfavorable  features.  As  the  temperature  at  8  p.m.  was 462  ANTIPNEUMOCOCCUS IMMUNE BODIES 
102°F., it was decided to administer another dose of serum, and 90 cc. were given, 
without  any reaction.  The  test  of  the  patient's  serum  obtained  before  this 
treatment showed that the agglutinins  had fallen slightly, agglutination occurring 
in a dilution of 1 : 15, but after the treatment the titer again rose to 1 : 40.  Fol- 
lowing this treatment the patient made a good recovery. 
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T~xT-FIG. 4.  Chart  showing the  curve of  the  agglutlnin titer and the  tem- 
perature curve of R. R. 
In this case, therefore, which was mild or of only moderate severity, 
treated early in the disease, the administration of immune serum was 
followed  by  a  satisfactory  concentration of  antibodies in  the  blood 
and there was no evidence of fixation or neutralization  of the injected 
immune substances.  This is graphically shown in Text-fig. 4. RUFUS COLE  463 
Case 2.--1. S., tailor; age 32 years.  This patient wasadmitted about 8 hours fol- 
lowing the initial chili.  There were definite signs of involvement of both lower 
lobes and he presented all the characteristic features of acute lobar pneumonia. 
His temperature on admission was  103.5°F., pulse 120, respirations 48.  He ap- 
peared seriously sick; the blood culture taken on admission was positive.  The 
diagnosis of the type of infecting organism was made by inoculation of sputum 
TExT-FIG. 5.  Chart  showing  the  curve  of  the  agglutinin titer  and  the  tem- 
peratu're curve of I. S. 
iutoa mouse, and at 12 midnight, 12 hours after admission, he was given his first 
treatment.  As the curves presented in Text-fig. 5  show, the first dose of serum 
imparted to the blood a well marked power of agglutination, and each subsequent 
dose was followed by an increase of this property.  With the increase of aggluti- 
nins in the blood there occurred an improvement in the patient's condition, the 
temperature fell, and he finally recovered completely. 464  ANTIPNEUMOCOCCUS  IMMUNE  BODIES 
The two examples given above illustrate the effects of serum treat- 
ment in  the  cases due  to Type I  infection,  when  the serum is given 
early and in large amounts,  and when the infection has not reached 
too  high  a  grade  before  the  treatments  are  commenced.  Since  in 
twenty~eight out of the thirty cases recovery followed the administra- 
tion of the serum,  we did not have great opportunity to study cases 
of this  type in which  the  serum  was not  effective.  In  all  the  cases 
treated  with  this  type of  serum  agglutinins  could  be demonstrated 
in  the  patient's  blood 2  to 3  minutes  after  the  administration  of  75 
to  100  cc.  of  serum.  The  agglutinating  power  varied  somewhat, 
though  in  most  cases  it  occurred  with  a  dilution  of  1:10  or  more. 
The  refinements  of the method  are  not sufficient  to justify our  cal- 
culating in each case the probable dilution and the consequent prob- 
able loss in agglutinins  in the short interval  elapsing before the first 
tests were made.  In genera], where the administration  of subsequent 
doses of the serum has not led to a prompt increase of the agg]utinins 
in the blood above the previous level the fall of temperature has been 
longer delayed and more serum has been required  than  in  the  cases 
in which a  regular step-like rise  took place.  In comparing  the  tem- 
perature  and  agglutination curves in these cases it has been necessary 
to  keep in mind  the  fact  that  the  temperature  alone  does not  offer 
a safe and sure criterion for judging the patient's condition and there- 
fore for  the  effectiveness of the  serum.  In  view of this  fact it  has 
been  surprising  to  see  the  considerable  uniformity  with  which  the 
temperature  and  agglutination  curves  run  in  opposite  directions. 
With rise of agglutinating  power the temperature curve falls. 
Of more ~mportance than  the immediate rise in agglutinins  follow- 
ing the first dose is probably the persistence of the  agglutinins  in  the 
blood  during  the  subsequent  8  to  10  hours  elapsing  before the fol- 
lowing dose of serum is given.  In only five of the cases did a decrease 
during this period occur.  In three of the cases the loss occurred only 
following  the  first  dose.  Following  the  subsequent  doses  the  con- 
centration  reached  a  high  level  and  persisted.  The  data  in  these 
three cases is not sufficient to enable us to state categorically that this 
loss indicated a greater severity of infection, though taken in connec- 
tion with our other observations this seems probable.  Two of these 
three  cases were treated  on  the 4th day and  one on the 6th.  Tlley RUFUS  COLE  465 
required  two,  three,  and  four  doses  of  serum  respecti ely  and  all 
made good recoveries following the serum treatment.  In one of the 
other cases in which the agglutinating power disappeare  d  before the 
following dose was  given,  the  concentration of immune bodies  fol- 
lowing the first three doses was such that agglutination did not occur 
with dilutions greater than 1 : 5, and following the first two doses this 
power disappeared completely before the subsequent dose was given. 
It was only after numerous doses had  been given that  the concen- 
tration  of agglutinins  reached any considerable  level and persisted. 
Altogether this patient required eleven doses of serum given over  7 
days.  Treatment was  commenced in  this  patient  on  the 2nd  day, 
but it was not pushed with great vigor at the start, the first dose being 
80 cc., with 18 hours elapsing before the administration of the second 
dose of 70 cc., and 12 hours again elapsing before the administration 
of the  third  dose  of 80  cc.  This  case suggested very strongly the 
inadvisability  of  inactive  treatment  at  the  start.  This  patient 
ultimately recovered and  there  occurred no  extension of the lesion 
to  other lobes, but the temperature remained high for 10  days and 
he was very ill.  Finally, the last case in which the agglutinins dis- 
appeared  between  subsequent  doses  and  in  which  there  occurred 
di~culty in causing a  persistent concentration of immune bodies in 
the patient's blood by the administration of immune serum was one 
of the  two  cases which ended fatally,  The  curves taken from  the 
record of this case are shown in  Text-fig. 6.  It is apparent from the 
curves  that  it  was  not  until  treatment  had  been  continued  for  3 
days, and nine doses had been given, that a persistent concentration 
of immune bodies at a high level was attained.  Even following this 
there was a constant tendency for the concentration of immune bodies 
in the serum to fall, rather than to rise. 
It should  be  noted  that  the  treatment in  this  patient  was  com- 
menced only on the 6th day, and 11 and 13 hours elai~sed between the 
first and second, and the second and third doses, respectively.  He was 
desperately ill on admission; temperature 104.5°F., pulse 136, and the 
blood culture showed an extremely high grade of infection, over 300 
colonies per cc.  In spite of this he lived until the 12th day.  It seems 
that  in  this  case  the  serum prolonged  life.  The  infection  and  in- 
toxication,  however,  at  the  start  were  so  great  that,  although  the ~  ~_  ~,.~ 
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infection could be kept down, the intoxication could not be recovered 
from.  In  this  instance it  is  likely,  judging  from  the  experimental 
observations, that the presence of large amounts of soluble inhibiting 
substances in the blood prevented the action of the immune serum. 
It is probable  that in such cases very late in the disease these sub- 
stances may be so large in amount that no practical amount of immune 
substances  can  neutralize  them.  If  these  conceptions  are  correct, 
the importance of giving very large doses of immune serum at  the 
beginning of treatment is  apparent. 
In  the  other fatal case,  persistent high  concentration of immune 
bodies in the patient's blood was obtained without difficulty  Never- 
theless, the patient's condition did not improve and repeated doses of 
serum were administered.  Type I  pneumococci had been  obtained 
from the sputum,  and  the blood culture showed 47  colonies per cc. 
of the same organisms.  Treatment was  commenced on the 6th day 
and the patient died on the 10th day.  The pathological changes were 
extensive  in  both  lungs.  The  autopsy  showed  a  very  widespread 
tuberculous involvement of both upper lobes and the upper portion 
of the lower lobe on each side.  At the  base  of one lung, however, 
was  a  small  area of complete consolidation, differing in  appearance 
from the remainder of the tuberculous lung.  This proved on study 
to be a  typical acute diffuse pneumonic process and from it Type I 
pneumococci were cultivated.  We have here an instance in which the 
serum  was  apparently  effective  against  the  specific  infection,  but 
death  occurred on  account  of  factors  associated  with  the  primary 
and extensive tuberculosis. 
A  further interesting case in this connection was one due to Type 
IV infection.  Owing to a  mistake in the early determination of the 
type of infection the patient received several doses of Type I  serum 
before the mistake was discovered.  In this patient, although he was 
quite ill, the administration of the serum caused a prompt appearance 
of agglutinins in  the  blood  and  this  increased with  the  subsequent 
doses, without any material fall. 
These  studies  of  agglutination  curves  in  the  cases  of Type I  in- 
fection,  however, while  instructive  and  suggestive,  do  not  after  all 
give definite proof that the effect of immune serum is limited by the 
presence  of  soluble  substances  in  the  blood.  When  they  are  con- 468  ANTI]?NEUMOCOCCUS  IMMUNE  BODIES 
sidered,  however,  in  the  light  of  the  observations  on  the  Type  I1 
cases which  follow, the  evidence becomes much  more  suggestive. 
Cases Due to Type H  Infection. 
The  reader  shou]d  be  reminded  at  the  outset  that  it  has  been 
impossible  to produce a  serum  against  Type II  pneumococci which 
is as active either in vitro  or in vivo  as is the  serum against  Type I 
pneumococci.  Whereas  the  horse  serum  against  Type  I  infection 
is of such a strength that 0.2 cc. will regularly protect a mouse against 
0.1 cc. of virulent culture, it has been impossible to produce an immune 
Type II serum of any greater activity than that 0.2 cc. will protect a 
mouse  against  0.01  cc.  of  culture.  Moreover,  the  active  Type  I 
sera usually cause agglutination of homologous organisms in dilutions 
of  1:400  or  over;  the  Type  II  sera  usually  cause  agglutination  in 
dilutions  no  greater  than  1:200.  It  should  also be noted  that  the 
capsule formation  of Type II pneumococci is more highly developed 
than is that of Type I pneumococci.  Dochez and Avery  9 have pointed 
out that production of precipitable substances in the blood and urine 
of infected animals apparently bears some relationship to this property 
of capsule development, the Type III organisms,  which possess large 
capsules,  forming  most  of  this  substance,  the  Type  II  organisms, 
which have smaller capsules, producing less, and the Type I organisms, 
which have small capsules, producing  still less.  While it is not cer- 
tain  that  the  substances  in  the  infected  animals  which  give  rise  to 
fixation  of antibodies  are  identical  with  those concerned in  the  pre- 
cipitation phenomenon,  it seems likely that this is the case. 
Studies of the  agglutinin  content of the  blood were made  in  nine 
cases of Type II infection which received Type II  serum.  Of these 
patients, four recovered and five died.  Of the patients who recovered, 
in  two  treatment was commenced on the 3rd  day,  in one on the 4th 
day, and  in  one on the 5th day.  Of the fatal  cases,  treatment  was 
commenced in one on the 3rd day, in one on the 5th day, and in the 
others  on  the 6th  day.  In  all  the  four  cases  which  recovered,  a 
satisfactory  and persistent  concentration  of agglutinins  in  the  blood 
appeared.  In  one  of  the  fatal  cases,  practically  no  agglufinins  ap- 
Dochez, A. R., and Avery, O. T., J. Exp. Med., 1917, xxvi, 477. ~t~us  COLE  469 
peared in  the  blood in  spite  of four doses of serum;  in  one  a  saris- 
factory  concentration  appeared  only  after  three  doses,  and  then 
disappeared;  in  another  a  satisfactory  concentration  was  obtained 
only  on  the  9th  day,  after  five  doses  of  serum;  in  another,  while 
a  satisfactory concentration  of agglurinins  was obtained  on  the  (lay 
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TExT-FIG. 7.  Chart  showing the curve  of the agglutinln tiler and  the tem- 
perature curve of E. F. 
treatment was commenced, the 6th day, the patient was at that time 
suffering from meningitis,  from which  he  died 2  days later.  In  the 
remaining case only one dose of serum was given, 2 hours before death; 
no  agglutinating  power  appeared  in  the  blood.  Text-figs.  7  and  8 
show graphically the resu]ts of observations made in two of the fatal 
cases. 470  ANTIPNEUMOCOCCUS  IMMUNE  BODIES 
Case I.--E. F., porter; age 46 years.  This patient was admitted on the 5th day 
of the disease with an  extensive lung involvement and  very severe septicemia, 
the blood cultures showing  1,000  colonies per cc.  His condition was very seri- 
ous ; temperature  104°F., pulse  104, respirations 64, and, in spite of four doses of 
serum  within  24  hours,  the  patient  died.  It  will be  noted  that  immediately 
following the administration of 75 cc. of serum, the undiluted blood showed power 
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TExT-FIG. 8.  Chart  showing the curve of the  agglutinin titer and  the tem- 
perature curve of S. F. 
of agglutination, but tbis property had disappeared within 7 hours, and follow- 
ing the  subsequent  doses the  blood showed  no  agglutinating power whatever. 
It is evident, therefore, that in this severely infected case the immune bodies in 
the serum disappeared from the blood as fast as they were administered. 
Case 2.--S. F., clerk; age 31 years.  This patient, though admitted early in the 
disease, was extremely ill; temperature 103.3°F.,pulse 160, respirations 56.  The 
blood culture showed 400 colonies per cc. and the following morning, before the RUFUS  COLE  471 
first  dose of serum was given,  the  culture  showed  1,600  colonies  per cc.  Fol- 
lowing the first two doses of serum there occurred an immediate appearance of 
agglutinins in the blood in low dilutions, which, however, disappeared or became 
minimum in amount before the succeeding doses.  In spite of the extreme grade 
of blood infection, the number of organisms present in the blood diminished follow- 
ing these two doses, the cultures on the morning of the 4th day showing only 20 
colonies per cc.  There was a  satisfactory increase in agglutinins following the 
third dose, but it will be noted that 15 hours were allowed to elapse between this 
dose and the succeeding one, and during this time the agglutinins had entirely 
disappeared and the subsequent doses produced little or no effect on the agglntinin 
content (Text-fig. 8).  The patient died on the 6th day. 
Five  patients  suffering from  Type  II  infection who  received  no 
serum were also studied to observe the appearance of agglutinins in 
the blood.  All these recovered.  In  four of these instances at  the 
end of the disease there developed well marked power of agglutination; 
in one of them agglutination in the serum obtained on the 10th day 
occurred in a dilution of 1 : 100.  In the fifth no agglutinins appeared 
in  the blood,  though this  was not studied later than the  12th  day. 
This patient received optochin, as did, however, several of the cases 
in which agglutinins devploped. 
DISCUSSION. 
Neufeld and Haendel,  ~  0 Dochez 11 and others have shown that specific 
immune  substances  usually  appear  in  the  blood  during  recovery 
from '.obar pneumonia.  This is  shown by an increase in protective 
power of the blood for mice against homologous infection.  C|ough  1= 
has  made  similar  observations  and  he  and  others  have  also  noted 
that  in  certain instances  the  protective  power  is  accompanied  by 
the power of inducing in  vitro  phagocytosis of virulent homologous 
pneumococci  which  are  not  phagocytable  in  normal  serum.  It 
•  would  seem,  therefore,  that  bacteriotropins  represent  one  form  of 
immune body playing a  part in this protective phenomenon.  BulW 
has brought forward experimental evidence which indicates strongly 
that  the phenomenon of agglutination is of great importance in the 
I0 Neufeld, F., and Haendel, Arb. k. Gsndhlsamte., 1910, xxxiv,  166. 
11 Dochez, A. R., J. Exp. Med., 1912, xvi, 665. 
1= Clough, P. W., Bull. Johns Hopkins Hosp.,  1913, xxiv, 295. 
1~ Bull, C. G., J. Exp. Med., 1915, xxii, 457. 472  ANTIPNEUMOCOCCUS  IMMUNE  BODIES 
action of immune serum in  pneumococcus infection.  It  is  possible 
that  several  different  antibodies  or  phenomena  take  part  in  the 
mechanism of pneumococcus humoral immunity.  The  observations 
I  have mentioned, as well as unpublished observations made in this 
laboratory,  indicate  strongly that natural recovery in  pneumonia is 
associated with the development of humoral immunity and probably 
occurs because of this development.  In the individual case, however, 
the  factors which determine recovery or death  cannot be  stated  so 
simply.  In  mild  cases  probably  a  very  slight  grade  of  humoral 
immunity may  be  sufficient  to  prevent  progress  of  the  disease,  a 
grade  of  immunity  which  can  be  detected  with  difficulty by  our 
present means.  In other instances the reaction required on the part 
of the body may be very great and the immunity phenomena exhibited 
by the serum when tested outside the body may be very vigorous and 
marked. 
The phenomenon of agglutination offers one ready means for testing 
the degree of humoraJ immunity.  It is, however, not the only  one 
and it is unsafe to judge of the immunological effectiveness of a serum 
solely  by  its  agglutinating  strength.  The  protective  power  and 
agglutinating power of immune horse  serum,  however,  tend  to  run 
parallel.  Consequently,  the  study  of  agglutinating  power  of  the 
blood  of patients,  such  as  has  been  made  in  the  present  instance, 
must be  of considerable value in indicating the presence or absence 
of  humoral  immunity.  If  recovery  in  pneumonia  is  due  to  the 
development  of  humoral  immunity,  the  study  of  its  appearance 
during  recovery and especially of its  appearance following treatment 
with immune serum, should be of significance.  In commencing the 
study it was thought that the method might be employed to graduate 
the dosage of immune serum in the treatment of  the individual case. 
If recovery is due to the appearance of immune bodies in the blood, 
the  ideal  serum  treatment would be  such  that  sufficient serum be 
administered to produce the required concentration of immune bodies 
and no more.  It soon became apparent, however, that such a method, 
testing  the blood before and  after the administration of each dose, 
involved so much time and labor  that  it would not be  of practical 
value.  It has seemed, however, that the repeated tests of the serum 
in  a  series  of  cases,  as  has  been  done  here,  give  us  considerable RtrFVS coLv.  473 
knowledge of the mode of  action of  the  serum and  offer valuable 
suggestions  for  the  routine  dosage and  mode of application  of  the 
serum.  The  studies  have  further  indicated  strongly  that  during 
infection not  only must  sufficient immune substances  be  added to 
bring  about  a  concentration sufficient to  sensitize  all  the  bacteria, 
produce  their  agglutination,  opsonlfication,  etc.,  but  in  addition 
there  must  be  a  sufficient amount  administered  to  neutralize any 
soluble  substances  present  in  the  serum  which  have  the  property 
of  neutralizing  and  fixing  the  immune  substances.  It  is  realized 
that the occurrence of these soluble, fixing substances in the blood of 
infected patients  has  not been directly demonstrated.  The  experi- 
mental  observations  in  animals  previously  described,  however, 
make  it  altogether  probable  that  these  substances  are  present  in 
severe  infections.  It  must  be  admitted  that  in  most  instances 
where there was failure of immune substances to appear in the blood, 
or where the immune bodies disappeared very rapidly following their 
administration, bacteriemia was shown to be present before the first 
dose of serum was administered.  In several cases, however, the blood 
infection could not be demonstrated after the first dose, and never- 
theless, rapid disappearance of the immune bodies occurred following 
the subsequent doses.  In one instance in which the rapid disappear- 
ance of immune bodies occurred, the blood cultures taken both before 
and  after  the  administration  of  serum  were  sterile.  However,  it 
seems likely that in all cases when fixation of immune bodies occurs, 
blood infection has at some time been present, though the possibility 
that the fixing substances may, in certain instances,  arise entirely in 
local foci cannot be excluded. 
The nature of the substances bringing about the fixation can at pres- 
ent only  be  conjectured.  The demonstration, however, by Dochez 
and Avery  9 of substances giving rise to precipitates in the blood and 
urine of infected patients makes it probable that the same substances 
are responsible for the phenomenon of fixation that we have studied. 
They have apparently shown that these substances may be excreted 
or formed by the bacteria during their growth, and it is also probable 
that substances contained in the  bacteria  and  set  free  during  their 
dissolution may give rise to the same phenomenon. 
The observations made in this study have a practical bearing on the 474  ANTIPNEUMOCOCCUS  IMMUNE  BODIES 
question of the therapeutic administration of immune serum.  The 
amount of serum necessary to be given does not depend merely on the 
weight of the patient and therefore on the consequent dilution of the 
serum in the body.  It is also not entirely dependent on the degree 
of  infection  present.  If  the  patient  is  treated  early  before  large 
amounts of the soluble substance are present, a moderate amount of 
serum may be  sufficient, even though  the grade  of blood  infection 
may be considerable.  On the other hand,  if the infection has  con- 
tinued for a  considerable time, and large amounts of soluble, fixing 
substance  are present in  the blood,  the  amount  of serum required 
may be very large.  It is therefore evident that it is important that 
the patient be treated as early as possible and before large amounts 
of  these  fixing  substances  are  formed.  Moreover,  the  importance 
of treating very actively at  the start  in  order that  all  these fixing 
substances may be  at  once neutralized and  the progress  of the in- 
fection immediately and entirely overcome is  apparent.  It is there- 
fore our plan  at present to  treat all  patients with Type I  infection 
with  large  initial  doses,  and  to  repeat  the  treatment  every 6  to  8 
hours as long as may be necessary.  It is possible that the Type II 
serum is less effective than Type I  serum not only because its  con- 
centration of immune bodies is less than that of Type I  serum, but 
also because the power of pneumococci of this  type to produce fixing 
substances is more highly developed than is that of pneumococci of 
Type I. 
CONCLUSIONS. 
I. In empyema  fluids resulting from infection with pneumococci 
there are present large amounts  of soluble substances  which have 
the property of neutra]izing  pneumococcus  antibodies. 
2. Similar  substances are found in the blood of infected rabbits. 
3.  When immune serum is  injected into  infected rabbits  the im- 
mune substances disappear very quickly, and therefore are prevented 
from activity in overcoming the  infection. 
4.  When immune serum is  administered to  patients  severely  in- 
fected  with  pneumococci,  the  immune  bodies  may  also  disappear 
very rapidly, and this disappearance is probably associated with the 
presence of such soluble substances in the  blood. ~uFus  coL~  475 
5.  The  serum  only becomes  effective when  these  substances  are 
neutralized. 
6.  The  study of agglutination curves is  of value in  showing  why 
in  certain instances  favorable  results have not  followed the  use  of 
immune serum. 
7.  It is important that in severely infected patients the  serum  be 
administered early in the disease and that the initial dosage be  large. 